Delivery Order SPE2DB22D3016-SPE2DB24FALC2
Award Date 2/1/24
Potential Completion Date 2/23/24
Potential Value $8.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the pharmaceutical product ONIVYDE 43 MG/10 ML VIAL 10ML. The delivery order has a firm fixed price of $10,112.40 and a period of performance through April 29, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to the DLA, providing a wide range of pharmaceutical products and medical supplies in support of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ONIVYDE 43 MG/10 ML VIAL 10ML pharmaceutical products. The order has a potential value of $9,772.62 and a completion date of January 18, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This delivery order is part of Amerisourcebergen Drug Corp's broader support of DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $5,345.67 and a performance period through June 3, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,056.20 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product. This contract has a completion date of June 20, 2024 and a firm fixed price pricing type. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,168.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The $8,427.00 firm-fixed price contract is for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product, with a period of performance through May 28, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. government, particularly the Department of Defense (DoD) and Department of...
- The Defense Logistics Agency awarded a delivery order valued at $10,691.34 to AmerisourceBergen Drug Corp for the supply of Onivyde 43 mg/10 ml vials on April 24, 2025, with an ultimate completion date of May 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Onivyde is a specialized oncology medication used in cancer treatment, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of ONIVYDE 43 mg/10 ml vials with a ceiling value of $11,267.04 under a firm fixed-price contract structure. This is a non-set-aside competitive award with a completion date of January 20, 2026, with performance occurring at the vendor's Conshohocken, Pennsylvania location. ONIVYDE (irinotecan liposome injection) is a specialized oncology pharmaceutical used in cancer...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Onivyde 43 mg/10 mL vials. This firm fixed-price contract, valued at $19,596.36, represents a non-set-aside competitive award with a completion date of January 15, 2026. AmerisourceBergen will fulfill this order from its Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- This federal contract award is for the pharmaceutical product ONIVYDE 43 MG/10 ML VIAL 10ML, with a ceiling value of $5,056.20. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 4, 2024 and is structured as a Firm Fixed Price Delivery Order. The award does not indicate any set-aside requirements,...